StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn total assets

Total assets on the balance sheet at the end of each period.

CytoDyn's total assets was $19.05M at Aug 31, 2026. For fiscal 2026 it was $13.97M, down 22.6% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $132.08M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2026May 31, 2026$13.97M-22.6%
FY2025May 31, 2025$18.05M+62.1%
FY2024May 31, 2024$11.14M-1.4%
FY2023May 31, 2023$11.29M-61.3%
FY2022May 31, 2022$29.19M-77.9%
FY2021May 31, 2021$132.08M+161.5%
FY2020May 31, 2020$50.51M+142.0%
FY2019May 31, 2019$20.87M+326.1%
FY2018May 31, 2018$4.90M-39.2%
FY2017May 31, 2017$8.06M-41.6%
FY2016May 31, 2016$13.79M+194.6%
FY2015May 31, 2015$4.68M-44.5%
FY2014May 31, 2014$8.43M+102.7%
FY2013May 31, 2013$4.16M+288.3%
FY2012May 31, 2012$1.07M-46.3%
FY2011May 31, 2011$1.99M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$19.05M+41.3%
Q4 FY2026CQ2 2026May 31, 2026$13.97M-22.6%
Q3 FY2026CQ1 2026Feb 28, 2026$18.50M-12.7%
Q2 FY2026CQ4 2025Nov 30, 2025$8.94M-64.1%
Q1 FY2026CQ3 2025Aug 31, 2025$13.48M-51.9%
Q4 FY2025CQ2 2025May 31, 2025$18.05M+62.1%
Q3 FY2025CQ1 2025Feb 28, 2025$21.19M+106.3%
Q2 FY2025CQ4 2024Nov 30, 2024$24.88M+169.2%
Q1 FY2025CQ3 2024Aug 31, 2024$28.02M+125.8%
Q4 FY2024CQ2 2024May 31, 2024$11.14M-1.4%
Q3 FY2024CQ1 2024Feb 29, 2024$10.27M+45.2%
Q2 FY2024CQ4 2023Nov 30, 2023$9.24M-67.5%
Q1 FY2024CQ3 2023Aug 31, 2023$12.41M-57.5%
Q4 FY2023CQ2 2023May 31, 2023$11.29M-88.0%
Q2 FY2023CQ4 2022Nov 30, 2022$7.07M-93.2%
Q1 FY2023CQ3 2022Aug 31, 2022$28.39M-73.0%
Q4 FY2022CQ2 2022May 31, 2022$29.19M-77.9%
Q3 FY2022CQ1 2022Feb 28, 2022$94.08M-17.2%
Q2 FY2022CQ4 2021Nov 30, 2021$103.70M-27.9%
Q1 FY2022CQ3 2021Aug 31, 2021$104.97M+12.4%
Q4 FY2021CQ2 2021May 31, 2021$132.08M+161.5%
Q3 FY2021CQ1 2021Feb 28, 2021$113.65M+192.8%
Q2 FY2021CQ4 2020Nov 30, 2020$143.76M+702.4%
Q1 FY2021CQ3 2020Aug 31, 2020$93.36M+407.8%
Q4 FY2020CQ2 2020May 31, 2020$50.51M+142.0%
Q3 FY2020CQ1 2020Feb 29, 2020$38.82M+90.0%
Q2 FY2020CQ4 2019Nov 30, 2019$17.92M-12.1%
Q1 FY2020CQ3 2019Aug 31, 2019$18.39M+103.6%
Q4 FY2019CQ2 2019May 31, 2019$20.87M+326.1%
Q3 FY2019CQ1 2019Feb 28, 2019$20.43M+146.6%
Q2 FY2019CQ4 2018Nov 30, 2018$20.39M+214.2%
Q1 FY2019CQ3 2018Aug 31, 2018$9.03M+47.4%
Q4 FY2018CQ2 2018May 31, 2018$4.90M-39.2%
Q3 FY2018CQ1 2018Feb 28, 2018$8.28M-43.9%
Q2 FY2018CQ4 2017Nov 30, 2017$6.49M-58.6%
Q1 FY2018CQ3 2017Aug 31, 2017$6.13M-34.1%
Q4 FY2017CQ2 2017May 31, 2017$8.06M–
Q3 FY2017CQ1 2017Feb 28, 2017$14.76M–
Q2 FY2017CQ4 2016Nov 30, 2016$15.67M–
Q1 FY2017CQ3 2016Aug 31, 2016$9.29M–

More CytoDyn figures

See a number that looks wrong?